Why Curing Is Not the Business Model
Published 2026-01-28 · 3,461 views · 0m 33s
Watch on YouTube →
A 33-second argument that chronic disease management became more profitable than cures.
Summary
The video claims that pharmaceutical business models prioritize recurring revenue from chronic disease management over cures. The speaker describes an incentive structure where managed illness generates ongoing prescription refills and insurance premiums.
Topic
Healthcare & Medical Debt · also covers: System & Policy
Pain points addressed
I feel trapped in a system that profits from my illness
I suspect my treatment is designed for ongoing dependency, not recovery
I distrust pharmaceutical companies' motives